Insider · CIK 0001579510
Alexander Kaganowicz
Files at REFR (RESEARCH FRONTIERS INC). First filing -, latest -.
In brief
Alexander Kaganowicz files SEC Form 4 as director at REFR (RESEARCH FRONTIERS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Alexander Kaganowicz has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | REFR RESEARCH FRONTIERS INC | AGrant or award Stock Option (right to buy)derivative | +45,000 | $0.00 | $0 | 361,000 | Jan 5, 2026 |
| Dec 31, 2024 | REFR RESEARCH FRONTIERS INC | AGrant or award Stock Option (right to buy)derivative | +45,000 | $0.00 | $0 | 327,495 | Jan 2, 2025 |
| Dec 31, 2023 | REFR RESEARCH FRONTIERS INC | AGrant or award Stock Option (right to buy)derivative | +45,000 | $0.00 | $0 | 295,337 | Jan 5, 2024 |
Questions about Alexander Kaganowicz
Answered from the filings on this page, as of the latest one.
Is Alexander Kaganowicz buying or selling?
Alexander Kaganowicz has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Alexander Kaganowicz's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alexander Kaganowicz has 0.
Where does Alexander Kaganowicz file Form 4?
Alexander Kaganowicz has filed Form 4 at REFR (RESEARCH FRONTIERS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.